Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anticoagulants AND thrombophilia AND thrombosis AND venous thrombosis:

Renal venous thrombosis in neonates. Moudgil A et al. Curr Pediatr Rev. (2014)

Venous thrombosis: who should be screened for thrombophilia in 2014? Kyrle PA et al. Pol Arch Med Wewn. (2014)

Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Prandoni P et al. Thromb Haemost. (2015)

Search results

Items: 1 to 20 of 2078

1.

Recurrent pulmonary embolism associated with deep venous thrombosis diagnosed as protein s deficiency owing to a novel mutation in PROS1: A case report.

Huang X, Xu F, Assa CR, Shen L, Chen B, Liu Z.

Medicine (Baltimore). 2018 May;97(19):e0714. doi: 10.1097/MD.0000000000010714.

2.

Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Riess H, Ay C, Bauersachs R, Becattini C, Beyer-Westendorf J, Cajfinger F, Chau I, Cohen AT, Khorana AA, Maraveyas A, Renni M, Young AM.

Oncologist. 2018 Apr 12. pii: theoncologist.2017-0473. doi: 10.1634/theoncologist.2017-0473. [Epub ahead of print] Review.

PMID:
29650686
3.

Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency.

Ameku K, Higa M.

Case Rep Hematol. 2018 Jan 23;2018:5217301. doi: 10.1155/2018/5217301. eCollection 2018.

4.

Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism.

Bulato C, Campello E, Gavasso S, Maggiolo S, Tormene D, Simioni P.

Hamostaseologie. 2018 Feb;38(1):33-38. doi: 10.5482/HAMO-17-03-0013. Epub 2018 Feb 26.

PMID:
29536478
5.

Thrombophilia testing in children: What and when should be tested?

Nowak-Göttl U, van Ommen H, Kenet G.

Thromb Res. 2018 Apr;164:75-78. doi: 10.1016/j.thromres.2018.02.136. Epub 2018 Feb 21. Review.

PMID:
29518638
6.

Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review.

Bertoletti L, Benhamou Y, Béjot Y, Marechaux S, Cheggour S, Aleil B, Lellouche N, Dillinger JG, Delluc A.

Blood Rev. 2018 Feb 2. pii: S0268-960X(17)30029-2. doi: 10.1016/j.blre.2018.01.002. [Epub ahead of print] Review.

PMID:
29402471
7.

Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.

Janczak DT, Mimier MK, McBane RD, Kamath PS, Simmons BS, Bott-Kitslaar DM, Lenz CJ, Vargas ER, Hodge DO, Wysokinski WE.

Mayo Clin Proc. 2018 Jan;93(1):40-47. doi: 10.1016/j.mayocp.2017.10.007. Epub 2017 Dec 6.

PMID:
29217335
8.

[Deep vein thrombosis in uncommon localisations].

Erdmann A, Ney B, Qanadli SD, Calanca L, Mazzolai L.

Rev Med Suisse. 2017 Dec 6;13(586):2134-2137. French.

PMID:
29211373
9.

Norethisterone enanthate-induced cerebral venous sinus thrombosis (CVST).

Bahall M, Santlal M.

BMJ Case Rep. 2017 Nov 14;2017. pii: bcr-2017-222418. doi: 10.1136/bcr-2017-222418.

10.

Deep vein thrombosis in pediatric patients.

Jaffray J, Young G.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26881. Epub 2017 Nov 8. Review.

PMID:
29115714
11.

Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.

Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW.

BMJ. 2017 Oct 26;359:j4452. doi: 10.1136/bmj.j4452. Review.

12.

The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms.

Lee SY, Kim EK, Kim MS, Shin SH, Chang H, Jang SY, Kim HJ, Kim DK.

PLoS One. 2017 Oct 17;12(10):e0185785. doi: 10.1371/journal.pone.0185785. eCollection 2017.

13.

Deep-vein thrombosis in the era of high HIV and tuberculosis prevalence: A prospective review of its diagnosis and treatment in a quaternary centre.

Hodkinson KE, Mahlangu JN.

S Afr Med J. 2017 Sep 22;107(10):859-863. doi: 10.7196/SAMJ.2017.v107i10.12443.

14.

[Pulmonary Embolism Despite Rivaroxaban in an Obese Patient].

Schuh T, Stöllberger C.

Dtsch Med Wochenschr. 2017 Oct;142(20):1548-1551. doi: 10.1055/s-0043-114547. Epub 2017 Oct 10. German.

PMID:
29017215
15.

Thrombophilia Testing and Venous Thrombosis.

Connors JM.

N Engl J Med. 2017 Sep 21;377(12):1177-1187. doi: 10.1056/NEJMra1700365. Review. No abstract available.

PMID:
28930509
16.

Challenges of Anticoagulation Therapy in Pregnancy.

Fogerty AE.

Curr Treat Options Cardiovasc Med. 2017 Sep 14;19(10):76. doi: 10.1007/s11936-017-0575-x. Review.

PMID:
28913590
17.

Inferior vena cava atresia predisposing to acute lower extremity deep vein thrombosis in children: A descriptive dual-center study.

Tarango C, Kumar R, Patel M, Blackmore A, Warren P, Palumbo JS.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26785. Epub 2017 Aug 29.

PMID:
28853209
18.

European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology.

Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, di Minno M, Maino A, Martinelli I, Masuhr F, Aguiar de Sousa D, Stam J; European Stroke Organization.

Eur J Neurol. 2017 Oct;24(10):1203-1213. doi: 10.1111/ene.13381. Epub 2017 Aug 20.

PMID:
28833980
19.

Laboratory Testing for Activated Protein C Resistance (APCR).

Mohammed S, Favaloro EJ.

Methods Mol Biol. 2017;1646:137-143. doi: 10.1007/978-1-4939-7196-1_10.

PMID:
28804824
20.

An Overview of Thrombophilia and Associated Laboratory Testing.

Montagnana M, Lippi G, Danese E.

Methods Mol Biol. 2017;1646:113-135. doi: 10.1007/978-1-4939-7196-1_9. Review.

PMID:
28804823

Supplemental Content

Loading ...
Support Center